These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1352971)

  • 1. Is a point mutation in the mitochondrial ND2 gene associated with Alzheimer's disease.
    Petruzzella V; Chen X; Schon EA
    Biochem Biophys Res Commun; 1992 Jul; 186(1):491-7. PubMed ID: 1352971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of single nucleotide primer extension with mispairing PCR-RFLP in detecting a point mutation.
    Lin FH; Lin R
    Biochem Biophys Res Commun; 1992 Dec; 189(2):1202-6. PubMed ID: 1361728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 in Alzheimer's brains.
    Lin FH; Lin R; Wisniewski HM; Hwang YW; Grundke-Iqbal I; Healy-Louie G; Iqbal K
    Biochem Biophys Res Commun; 1992 Jan; 182(1):238-46. PubMed ID: 1370613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No association of mutations at nucleotide 5460 of mitochondrial NADH dehydrogenase with Alzheimer's disease.
    Kösel S; Egensperger R; Mehraein P; Graeber MB
    Biochem Biophys Res Commun; 1994 Sep; 203(2):745-9. PubMed ID: 8093052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The frequency of point mutations in mitochondrial DNA is elevated in the Alzheimer's brain.
    Chang SW; Zhang D; Chung HD; Zassenhaus HP
    Biochem Biophys Res Commun; 2000 Jun; 273(1):203-8. PubMed ID: 10873587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two point mutations in mitochondrial DNA of cytochrome c oxidase coexist with normal mtDNA in a patient with Alzheimer's disease.
    Qiu X; Chen Y; Zhou M
    Brain Res; 2001 Mar; 893(1-2):261-3. PubMed ID: 11223014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigations on the point mutations at nt 5460 of the mtDNA in different neurodegenerative and neuromuscular diseases.
    Janetzky B; Schmid C; Bischof F; Frölich L; Gsell W; Kalaria RN; Riederer P; Reichmann H
    Eur Neurol; 1996; 36(3):149-53. PubMed ID: 8738945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low mutational burden of individual acquired mitochondrial DNA mutations in brain.
    Simon DK; Lin MT; Ahn CH; Liu GJ; Gibson GE; Beal MF; Johns DR
    Genomics; 2001 Apr; 73(1):113-6. PubMed ID: 11352572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of mutations in mtDNA from patients suffering mitochondrial diseases.
    Schon EA; Naini A; Shanske S
    Methods Mol Biol; 2002; 197():55-74. PubMed ID: 12013813
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation of the clinical severity of Alzheimer's disease with an aberration in mitochondrial DNA (mtDNA).
    Brown AM; Sheu RK; Mohs R; Haroutunian V; Blass JP
    J Mol Neurosci; 2001 Feb; 16(1):41-8. PubMed ID: 11345519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial DNA mutations in Alzheimer's disease.
    Hutchin TP; Heath PR; Pearson RC; Sinclair AJ
    Biochem Biophys Res Commun; 1997 Dec; 241(2):221-5. PubMed ID: 9425253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain.
    Lin MT; Simon DK; Ahn CH; Kim LM; Beal MF
    Hum Mol Genet; 2002 Jan; 11(2):133-45. PubMed ID: 11809722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of human mitochondrial DNA mutations.
    Andreu AL; Martí R; Hirano M
    Methods Mol Biol; 2003; 217():185-97. PubMed ID: 12491933
    [No Abstract]   [Full Text] [Related]  

  • 14. Genotypic analysis of N-ethyl-N-nitrosourea-induced mutations by Taq I restriction fragment length polymorphism/polymerase chain reaction in the c-H-ras1 gene.
    Chiocca SM; Sandy MS; Cerutti PA
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5331-5. PubMed ID: 1351680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RFLP analysis for APP 717 mutations associated with Alzheimer's disease.
    Zeldenrust SR; Murrell J; Farlow M; Ghetti B; Roses AD; Benson MD
    J Med Genet; 1993 Jun; 30(6):476-8. PubMed ID: 7686976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mitochondrial DNA 3243, 3316 point mutations and type 2 diabetes mellitus].
    Tang J; Li J; Tian X; Kong Q; Zhang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Apr; 22(2):198-200. PubMed ID: 15793785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel amyloid precursor protein gene mutation (codon 665Asp) in a patient with late-onset Alzheimer's disease.
    Peacock ML; Murman DL; Sima AA; Warren JT; Roses AD; Fink JK
    Ann Neurol; 1994 Apr; 35(4):432-8. PubMed ID: 8154870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of a particular base substitution (3243 A to G) in mitochondrial DNA of tissues of ageing humans.
    Zhang C; Linnane AW; Nagley P
    Biochem Biophys Res Commun; 1993 Sep; 195(2):1104-10. PubMed ID: 8373389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic basis of Alzheimer's dementia: role of mtDNA mutations.
    Grazina M; Pratas J; Silva F; Oliveira S; Santana I; Oliveira C
    Genes Brain Behav; 2006; 5 Suppl 2():92-107. PubMed ID: 16681804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene.
    Chartier-Harlin MC; Crawford F; Houlden H; Warren A; Hughes D; Fidani L; Goate A; Rossor M; Roques P; Hardy J
    Nature; 1991 Oct; 353(6347):844-6. PubMed ID: 1944558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.